Cited by 12Nutrition and Health in AgingFrailty in Older AdultsHormonal and reproductive studies

Thresholds for clinical practice that directly link handgrip strength to remaining years of life: estimates based on longitudinal observational data

Open access
Scherbov, Sergei, Spitzer, Sonja, Steiber, Nadia·2022·BMJ Open

Abstract

Objective: Muscle strength is a powerful predictor of mortality that can quickly and inexpensively be assessed by measuring handgrip strength (HGS). What is missing for clinical practice, however, are empirically meaningful cut-off points that apply to the general population and that consider the correlation of HGS with gender and body height as well as the decline in HGS during processes of normal ageing. This study provides standardised thresholds that directly link HGS to remaining life expectancy (RLE), thus enabling practitioners to detect patients with an increased mortality risk early on. Design: Relying on representative observational data from the Health and Retirement Study, the HGS of survey participants was z-standardised by gender, age and body height. We defined six HGS groups based on cut-off points in SD; we use these as predictors in survival analyses with a 9-year follow-up and provide RLE by gender based on a Gompertz model for each HGS group. Participants: 8156 US American women and men aged 50–80 years. Main outcome measures: Z-standardised HGS and all-cause mortality. Results: Even slight negative deviations in HGS from the reference group with [0.0 SD, 0.5 SD) have substantial effects on survival. RLE among individuals aged 60 years with standardised HGS of [−0.5 SD, 0.0 SD) is 3.0/1.4 years lower for men/women than for the reference group, increasing to a difference of 4.1/2.6 years in the group with HGS of [−1.0 SD, −0.5 SD). By contrast, we find no benefit of strong HGS related to survival. Conclusions: HGS varies substantially with gender, age and body height. This confirms the importance of considering these heterogeneities when defining reference groups and risk thresholds. Moreover, survival appears to decrease at much higher levels of muscle strength than is assumed in previous literature, suggesting that medical practitioners should start to become concerned when HGS is slightly below that of the reference group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2021-058489

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previous studies have shown similar results on lean and fat mass and inconclusive results on the continuous or dose-response effect of protein intake effect on HGS.

    “Previous studies have shown similar results on lean and fat mass and inconclusive results on the continuous or dose–response effect of protein intake effect on HGS [20, 23, 24, 39].”

    From Sarcopenic Obesity Phenotype Index (SOP <i>i</i> ): A Population‐Based Study (2025) · cites this paper as [39]

    The Introduction (page unavailable) mentions age-related changes in responsiveness to protein intake, but does not assess protein intake’s continuous or dose–response effect on HGS. The Discussion’s mixed evidence concerns HGS and mortality, not protein intake; the passages found also do not address comparable results for lean and fat mass. Searched for lean and fat mass and for a protein-intake dose–response effect on HGS. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. [1]Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. The Lancet 2013; 381: 752– 62. 10.1016/S0140-6736(12)62167-9 PMC4098658 23395245 · DOI · Paper page
  2. [2]Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146– 57. 10.1093/gerona/56.3.M146 11253156 · DOI · Paper page
  3. [3]Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working group on sarcopenia in older people. Age Ageing 2010; 39: 412– 23. 10.1093/ageing/afq034 20392703 PMC2886201 · DOI · Paper page
  4. [4]Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16– 31. 10.1093/ageing/afy169 30312372 PMC6322506 · DOI · Paper page
  5. [6]Rijk JM, Roos PR, Deckx L, et al. Prognostic value of handgrip strength in people aged 60 years and older: a systematic review and meta-analysis. Geriatr Gerontol Int 2016; 16: 5– 20. 10.1111/ggi.12508 26016893 · DOI · Paper page
  6. [7]Mainous AG, Tanner RJ, Anton SD, et al. Grip strength as a marker of hypertension and diabetes in healthy weight adults. Am J Prev Med 2015; 49: 850– 8. 10.1016/j.amepre.2015.05.025 26232901 PMC4656117 · DOI
  7. [8]Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes Consortium. J Am Geriatr Soc 2020; 68: 1410– 8. 10.1111/jgs.16372 32150289 PMC12132920 · DOI · Paper page
  8. [9]Martin-Ruiz C, von Zglinicki T. Biomarkers of healthy ageing: expectations and validation. Proc Nutr Soc 2014; 73: 422– 9. 10.1017/S0029665114000147 24810550 · DOI
  9. [10]Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the prospective urban rural epidemiology (pure) study. Lancet 2015; 386: 266– 73. 10.1016/S0140-6736(14)62000-6 25982160 · DOI · Paper page
  10. [11]Bohannon RW. Muscle strength: clinical and prognostic value of hand-grip dynamometry. Curr Opin Clin Nutr Metab Care 2015; 18: 465– 70. 10.1097/MCO.0000000000000202 26147527 · DOI
  11. [12]Kuh D, Karunananthan S, Bergman H, et al. A life-course approach to healthy ageing: maintaining physical capability. Proc Nutr Soc 2014; 73: 237– 48. 10.1017/S0029665113003923 24456831 PMC3981474 · DOI
  12. [13]Lera L, Albala C, Leyton B, et al. Reference values of hand-grip dynamometry and the relationship between low strength and mortality in older Chileans. Clin Interv Aging 2018; 13: 317– 24 10.2147/CIA.S152946 29503536 PMC5826209 · DOI
  13. [14]Laukkanen JA, Voutilainen A, Kurl S, et al. Handgrip strength is inversely associated with fatal cardiovascular and all-cause mortality events. Ann Med 2020; 52: 109– 19. 10.1080/07853890.2020.1748220 32223654 PMC7877981 · DOI
  14. [15]Volaklis KA, Halle M, Meisinger C. Muscular strength as a strong predictor of mortality: a narrative review. Eur J Intern Med 2015; 26: 303– 10. 10.1016/j.ejim.2015.04.013 25921473 · DOI
  15. [16]Zhuang C-L, Zhang F-M, Li W, et al. Associations of low handgrip strength with cancer mortality: a multicentre observational study. J Cachexia Sarcopenia Muscle 2020; 11: 1476– 86. 10.1002/jcsm.12614 32910535 PMC7749566 · DOI
  16. [17]Xu X, Yang Z, Ma T, et al. The cut-off values of handgrip strength and lean mass index for sarcopenia among patients on peritoneal dialysis. Nutr Metab 2020; 17: 84. 10.1186/s12986-020-00506-3 PMC7542899 33062032 · DOI
  17. [19]McGrath R, Vincent BM, Peterson MD, et al. Weakness may have a causal association with early mortality in older Americans: a matched cohort analysis. J Am Med Dir Assoc 2020;; 21: 621-626.e2. 10.1016/j.jamda.2019.10.016 31786197 PMC7186143 · DOI
  18. [20]Steiber N. Strong or weak handgrip? normative reference values for the German population across the life course stratified by sex, age, and body height. PLoS One 2016; 11: e0163917. 10.1371/journal.pone.0163917 27701433 PMC5049850 · DOI
  19. [21]Kallman DA, Plato CC, Tobin JD. The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol 1990; 45: M82– 8. 10.1093/geronj/45.3.M82 2335723 · DOI · Paper page
  20. [22]Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One 2014; 9: e113637. 10.1371/journal.pone.0113637 25474696 PMC4256164 · DOI
  21. [23]Duchowny KA, Peterson MD, Clarke PJ. Cut points for clinical muscle weakness among older Americans. Am J Prev Med 2017; 53: 63– 9. 10.1016/j.amepre.2016.12.022 28190692 PMC5497994 · DOI
  22. [25]Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 2011; 40: 423– 9. 10.1093/ageing/afr051 21624928 · DOI · Paper page
  23. [26]Sanderson WC, Scherbov S. Measuring the speed of aging across population subgroups. PLoS One 2014; 9: e96289. 10.1371/journal.pone.0096289 24806337 PMC4012980 · DOI
  24. [29]Duchowny K. Do nationally representative cutpoints for clinical muscle weakness predict mortality? results from 9 years of follow-up in the health and retirement study. J Gerontol A Biol Sci Med Sci 2019; 74: 1070– 5. 10.1093/gerona/gly169 30052779 PMC6580687 · DOI
  25. [30]Bachettini NP, Bielemann RM, Barbosa-Silva TG, et al. Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working group on sarcopenia in older people. Eur J Clin Nutr 2020; 74: 573– 80. 10.1038/s41430-019-0508-8 31586126 · DOI

Cited by

Sorted by citations

Authors
Scherbov, S., Spitzer, S., & Steiber, N.
Affiliations
University of Vienna (AT)
Corresponding author
Steiber, Nadia
Venue
BMJ Open
Publisher
BMJ
Published
2022-07
Volume
12
Issue
7
Pages
e058489
ISSN
2044-6055 (ISSN-L)
OpenAlex
W4286567614
Cited by
12
References
4
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 2
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repository (IHS Vienna) (acceptedVersion)
  • IIASA PURE (International Institute of Applied Systems Analysis) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Vienna
Topics
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
grip strength, remaining life expectancy, mortality risk, cut-off values, muscle strength, Gompertz model, aging, gender differences, body height, older adults, mortality prediction
MeSH terms
Aging, Body Height, Cross-Sectional Studies, Female, Humans, Male, Hand Strength, Muscle Strength

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review